BioCryst Pharma (BCRX) PT Lowered to $14 at JMP Securities

January 8, 2024 1:41 AM EST Send to a Friend

JMP Securities analyst Jonathan Wolleben ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

BioCryst Pharma (BCRX) PT Lowered to $14 at JMP Securities

Member Login

Free News Feed